News

Filter by:

• Corporate
• Product
  • Induced pluripotent stem cell (iPSC) Platform
  • CTX cells for Stroke Disability
  • CTX cells for Critical Limb Ischaemia
  • hRPCs for Retinitis Pigmentosa
  • CTX-derived Exosomes
• Trial
  • Phase III clinical trial in stroke disability (PISCES-III)
  • Phase I clinical trial in stroke disability (PISCES)
  • Phase II clinical trial in stroke disability (PISCES-II)
  • Observational study in stroke
  • Phase I trial in critical limb ischaemia
  • Phase I/II clinical trial in retinitis pigmentosa